Oral endotoxin in healthy adults

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 82, Issue 6, 1996, Pages 637-643

  Leenstra, Thomas S ^a,c   Van Saene, Joris J M ^b   Van Saene, Hendrik K F ^c   Martin, Michael V ^c  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN;

ADULT; ARTICLE; BACTERIAL COUNT; FEMALE; GRAM NEGATIVE ANAEROBIC BACTERIA; HETEROZYGOTE; HUMAN; ISOLATION AND PURIFICATION; LIMULUS LYSATE TEST; MALE; MICROBIOLOGY; MOUTH; OROPHARYNX; REFERENCE VALUE; SALIVA; SENSITIVITY AND SPECIFICITY;

ADULT; CARRIER STATE; COLONY COUNT, MICROBIAL; ENDOTOXINS; FEMALE; GRAM-NEGATIVE ANAEROBIC BACTERIA; HUMANS; LIMULUS TEST; MALE; MOUTH; OROPHARYNX; REFERENCE VALUES; SALIVA; SENSITIVITY AND SPECIFICITY;

EID: 0030341219     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1079-2104(96)80438-0     Document Type: Article

References (40)

1. van Saene HKF, Stoutenbeek CP, Torres A. The abnormal oropharyngeal carrier state: symptom or disease? Respir Med 1992;86:183-6.
2. Mackowiak PA, Martin RM, Smith SW. The role of bacterial interference in the increased prevalence of oropharyngeal gram-negative bacilli among alcoholics and diabetics. Am Rev Resp Dis 1979;120:589-95.
3. Kerver AJH, Rommes JH, Mevissen-Verhage EAE, et al. Colonization and infection in surgical intensive care patients: a prospective study. Intensive Care Med 1987;13:347-51.
4. Marsh P, Martin MV, editors. Oral microbiology. 3rd ed. London: Chapman & Hall, 1992:27-55.
5. Johanson WG, Pierce AK, Sanford JP. Changing pharyngeal bacterial flora of hospitalized patients: emergence of gram-negative bacilli. N Engl J Med 1969;281:1137-40.
6. Courtney HS, Ofek I, Simpson WA, Hosty DL, Beachey EH. The binding of Streptococcus pyogenes to soluble and insoluble fibronectin. Infect Immun 1986;53:454-9.
7. Dal Nogare AR, Toews GB, Pierce AK. Increased salivary elastase precedes gram-negative bacillary colonization in postoperative patients. Am Rev Resp Dis 1987;135:671-5.
8. Sprunt K. Practical use of surveillance for prevention of nosocomial infection. Semin Perinatol 1985;9:47-50.
9. Kurrle E, Bhaduri S, Krieger D, et al. Risk factors for infections of the oropharynx and the respiratory tract in patients with acute leukemia. J Infect Dis 1981;144:128-36.
10. Marshall JC, Christou NV, Meakins JL. The gastro-intestinal tract: the "undrained abscess" of multiple organ failure. Ann Surg 1993;218:111-9.
11. van Saene HKF, Stoutenbeek CP, Faber-Nijholt R, van Saene JJM. Selective decontamination of the digestive tract contributes to the control of disseminated intravascular coagulation in severe liver impairment. J Pediatr Gastroenterol Nutr 1992;14:436-42.
12. van Saene JJM, Stoutenbeek CP, van Saene HKF, Matera G, Martinez-Pellus AE, Ramsay G. Reduction of the intestinal endotoxin pool by three different SDD regimens in human volunteers. J Endotoxin Res 1996;3:337-43.
13. Vollaard E J, Clasener HAL. Colonization resistance. Antimicrob Agents Chemother 1994;38:409-14.
14. Michalek SM, Kiyono H, Wannemuehler M J, et al. Lipopolysaccharide (LPS) regulation of the immune response: LPS influence on oral tolerance induction. J Immunol 1982;128:1992-8.
15. Fainstein V, Musher DM, Care Th R. Baterial adherence to pharyngeal cells during viral infection. J Infect Dis 1980;141:172-6.
16. Silness J, Loe H. Periodental disease in pregnancy. II. Correlation between oral hygiene and periodental conditions. Acta Odontol Scand 1964;24:747-59.
17. Spijkervet FKL, van Saene HKF, Panders AK, Vermey A. Colonisation index of the oral cavity: a novel technique for monitoring colonisation defence. Microb Ecol Health Dis 1989;2:145-51.
18. van Saene JJM, Stoutenbeek CP, van Saene HKF. Faecal endotoxin in human volunteers: normal values. Microb Ecol Health Dis 1992;5:179-84.
19. Elin RJ, Hosseini J. Clinical utility of the Limulus amoebocyte lysate (LAL) test. Prog Clin Biol Res 1985;189:307-27.
20. Kasper DL. Chemical and biological characterization of the lipopolysaccharide of Bacteroides fragilis subspecies fragilis. J Infect Dis 1978;134:59-66.
21. Sveen K, Hofstad T, Milner KC. Lethality for mice and chick embryos, pyrogenicity in rabbits and ability to gelate lysate from amoebocytes of Limulus polyphemus by polysaccharides from Bacteroides, Fusobacterium and Veillonella. Acta Pathol Microbiol Scand 1977;85:388-96.
22. Simon GL, Gelfand JA, Connolly RA, O'Donnell TF, Gorbach SL. Experimental Bacteroides fragilis bacteremia in a primate model: evidence that Bacteroides fragilis does not promote the septic shock syndrome. J Trauma 1985;25:1156-62.
23. Rayner BL, Willcox PA. Community-acquired bacteraemia: a prospective survey of 239 cases. QJM 1988;69:907-19.
24. van Saene HKF, Stoutenbeek CP, Geitz JN, et al. Effect of amoxycillin on colonisation resistance in human volunteers. Microb Ecol Health Dis 1988;1:169-77.
25. Suffredini AF, Fromm RE. Parker MM, et al. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 1989;321:280-7.
26. Laforce FM, Hopkins j, Trow R, Wang WLL. Human oral defenses against gram-negative rods. Am Rev Resp Dis 1976;114:929-35.
27. Daly CG. Seymour GJ, Kieser JB. Bacterial endotoxin: A role in chronic inflammatory periodontal disease? J Oral Pathol 1980;9:1-15.
28. Husebye E, Skar V, Hoverstad T, et al. Abnormal intestinal motor patterns explain enteric colonization with gram-negative bacilli in late radiation enterophathy. Gastroenterology 1995;109:1078-89.
29. Bertok L. Physico-chemical defense of vertebrate organisms: the role of bile acids in defense against bacterial endotoxins. Perspect Biol Med 1977;21:70-6.
30. Magnuson DK. Weintraub A, Pohlman TH. et al. Human endothelial cell adhesiveness for neutrophils, induced by E. coli lipopolysaccharide in vitro, is inhibited by B. fragilis lipopolysaccharide. J Immunol 1989;143:3025-30.
31. Maier RV, Hahnel GB, Pohlman TH. Endotoxin requirements for alveolar macrophage stimulation. J Trauma 1990;30(suppl 12):S49-S57.
32. Redan JA, Rush BF, McCullough JN, et al. Organ distribution of radio-labelled enteric Escherichia coli during and after hemorrhagic shock Ann Surg 1990;211:663-8.
33. Wesley-Alexander J, Gianotti L, Pyles T, et al. Distribution and survival of Escherichia coli translocating from the intestine after thermal injury. Ann Surg 1991;213:558-67.
34. Bone RC. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. Crit Care Med 1996;24:163-72.
35. Murray PR, Rosenblatt JE. Bacterial interference by oropharyngeal and clinical isolates of anaerobic bacteria. J Infect Dis 1976;134:281-5.
36. Bergmann OJ. Oral infections and septicaemia in immunocompromised patients with hematologic malignancies. J Clin Microbiol 1988;26:2105-9.
37. Tancrede CH, Andremont AO. Bacterial translocation and gram-negative bacteremia in patients with hematological malignancies. J Infect Dis 1985;152:99-103.
38. Deitch EA, Xu D, Franko L, Ayala A, Chaudry I. Evidence favouring the role of the gut as a cytokine-generating organ in rats subjected to hemorrhagic shock. Shock 1994;1:141-6.
39. Spijkervet FKL, van Saene HKF, van Saene JJM, et al. Effect of selective elimination of the oral flora on mucositis in irradiated head and neck cancer patients. J Surg Oncol 1991;46:167-73.
40. Selective Decontamination of the Digestive Tract Trialists' Collaborative Group. Meta-analysis of randomized controlled trials of selective decontamination of the digestive tract. Br Med J 1993;307:525-32.